FAINARDI, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.201
EU - Europa 12.690
AS - Asia 9.528
SA - Sud America 2.099
AF - Africa 291
OC - Oceania 152
Continente sconosciuto - Info sul continente non disponibili 3
Totale 41.964
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.899
RU - Federazione Russa 3.899
IT - Italia 3.104
PL - Polonia 3.046
SG - Singapore 2.647
CN - Cina 2.256
BR - Brasile 1.720
VN - Vietnam 1.290
HK - Hong Kong 1.182
KR - Corea 857
IE - Irlanda 835
SE - Svezia 429
FR - Francia 337
BD - Bangladesh 331
IN - India 282
DE - Germania 269
GB - Regno Unito 202
CA - Canada 180
ID - Indonesia 168
FI - Finlandia 156
AU - Australia 152
AR - Argentina 144
JP - Giappone 107
NL - Olanda 102
CI - Costa d'Avorio 89
JO - Giordania 82
EC - Ecuador 76
ES - Italia 64
CH - Svizzera 60
MX - Messico 55
IQ - Iraq 52
UA - Ucraina 49
MA - Marocco 47
ZA - Sudafrica 46
CO - Colombia 45
TR - Turchia 35
NG - Nigeria 34
PY - Paraguay 34
SA - Arabia Saudita 30
PK - Pakistan 29
CL - Cile 25
BE - Belgio 23
AE - Emirati Arabi Uniti 21
VE - Venezuela 21
UZ - Uzbekistan 20
AT - Austria 17
AZ - Azerbaigian 17
EG - Egitto 16
MY - Malesia 16
CZ - Repubblica Ceca 15
PE - Perù 15
LT - Lituania 13
PH - Filippine 13
BJ - Benin 12
DZ - Algeria 12
JM - Giamaica 12
GR - Grecia 11
RO - Romania 11
IL - Israele 10
KZ - Kazakistan 10
UY - Uruguay 10
KE - Kenya 9
TT - Trinidad e Tobago 9
AL - Albania 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
NP - Nepal 8
HN - Honduras 7
LV - Lettonia 7
PT - Portogallo 7
TH - Thailandia 7
TN - Tunisia 7
BH - Bahrain 6
CR - Costa Rica 6
KG - Kirghizistan 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
PS - Palestinian Territory 5
SV - El Salvador 5
CY - Cipro 4
DK - Danimarca 4
IR - Iran 4
LB - Libano 4
PA - Panama 4
TW - Taiwan 4
AO - Angola 3
BG - Bulgaria 3
MD - Moldavia 3
QA - Qatar 3
TM - Turkmenistan 3
BB - Barbados 2
BN - Brunei Darussalam 2
EE - Estonia 2
HR - Croazia 2
MK - Macedonia 2
ML - Mali 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
Totale 41.930
Salva come PNG Salva come JPEG
Città #
Warsaw 3.041
Santa Clara 3.031
Ashburn 2.419
Singapore 2.027
Fairfield 1.718
Hong Kong 983
Seoul 839
Dublin 813
Woodbridge 786
Seattle 673
Houston 637
Milan 600
Hefei 581
Cambridge 566
Wilmington 512
San Jose 445
Ho Chi Minh City 427
Altamura 388
Beijing 386
Lawrence 313
Ann Arbor 288
Los Angeles 281
Council Bluffs 280
Rome 270
Chandler 262
Florence 260
Hanoi 257
Lauterbourg 243
Princeton 216
Boston 205
The Dalles 200
Moscow 195
Buffalo 184
New York 184
Clifton 169
Mumbai 151
Melbourne 148
São Paulo 131
Dallas 103
San Diego 102
Munich 99
Jakarta 97
Helsinki 94
Kent 92
Tokyo 90
Abidjan 89
Bologna 77
Shanghai 70
Dong Ket 68
Medford 66
Boardman 64
Da Nang 60
Phoenix 58
London 57
Naples 56
Haiphong 53
Bern 51
Figino 51
Rio de Janeiro 51
Turin 50
Chicago 48
Orem 48
Paris 48
Toronto 47
Redondo Beach 45
Frankfurt am Main 44
Falls Church 43
Barcelona 38
Guangzhou 38
Hải Dương 33
Norwalk 33
Casablanca 31
Lappeenranta 31
Bengaluru 30
Turku 30
Abuja 29
Amsterdam 28
Porto Alegre 28
Atlanta 27
Bari 27
Belo Horizonte 27
Chennai 27
Guayaquil 26
Tianjin 26
Yubileyny 26
Baghdad 25
Biên Hòa 25
Brasília 25
Brooklyn 25
Hillsboro 25
Thái Bình 25
Curitiba 24
Montreal 24
Dearborn 23
Denver 23
Genoa 22
Palermo 22
Miano 21
Brescia 20
Johannesburg 20
Totale 27.914
Salva come PNG Salva come JPEG
Nome #
Selezione all’intervento endovascolare tra perfusione e circoli collaterali 404
Cerebrospinal fluid analysis and the determination of oligoclonal bands 326
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 312
Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference 307
Infection and HLA-G molecules in nasal polyposis 289
Amplitude Instability of Somatosensory Evoked Potentials as an Indicator of Delayed Cerebral Ischemia in a Case of Subarachnoid Hemorrhage 286
miRNAs expression analysis in paired fresh/Frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time PCR 284
A Practical Approach to Interpretation of CBF Measured by Mean of Xenon-CT in Patients with Traumatic Brain Injury 281
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III 281
Association between perihematomal cerebral blood volume and intracerebral hemorrhage expansion: A computed tomography perfusion study 277
Bimanual non-congruent actions in motor neglect syndrome: A combined behavioral/fMRI study 269
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures 263
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? 262
Computed Tomography Perfusion-Based Machine Learning Model Better Predicts Follow-Up Infarction in Patients with Acute Ischemic Stroke 261
A Commentary on the Use of Epstein-Barr Virus Specific Antibodies as Biological Markers in Multiple Sclerosis 260
Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage after Intravenous Alteplase Therapy 258
Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke 258
Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke 257
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 255
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 249
Angioplasty in acute middle cerebral artery stroke due to atrial fibrillation selected by CT perfusion: A case report 247
Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis 246
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 239
Temporal changes in blood-brain barrier permeability and cerebral perfusion in lacunar/subcortical ischemic stroke 237
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 237
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping 236
History of migraine and volume of brain infarcts: The italian project on stroke at young age (IPSYS) 230
Cerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patients 224
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 222
Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome 218
Cerebral blood volume ASPECTS is the best predictor of clinical outcome in acute ischemic stroke: A retrospective, combined semi-quantitative and quantitative assessment 218
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 218
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 216
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 216
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 216
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 212
Determinants of cerebral collateral circulation in acute ischemic stroke due to large vessel occlusion 209
Chlamydophila pneumoniae infection and its role in neurological disorders 208
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images 206
Some basic aspects of HLA-G biology 204
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 202
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 202
In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report 202
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 201
HLA-G molecules in autoimmune diseases and infections 201
CT perfusion and angiographic assessment of pial collateral reperfusion in acute ischemic stroke: The CAPRI study 196
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 193
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 193
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 189
Integrating novel neuroimaging measurements and circulating biomarkers for the prediction of secondary injury following stroke. the NIMBLE study. 188
Prevalence of non-stenotic vulnerable carotid plaques in embolic stroke of undetermined source 188
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 188
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis 188
Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion 187
Cerebrospinal fluid analysis and the determination of oligoclonal bands 185
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 185
Acute ischemic STROKE - from laboratory to the Patient's BED (STROKELABED): A translational approach to reperfusion injury. Study Protocol 184
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 184
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 183
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 183
25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis 181
Added value of multiphase CTA imaging for thrombus perviousness assessment 178
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 177
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor 176
Blood-Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis 176
Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset: A Real-World Experience 175
Multiplex matrix metalloproteinases analysis in the cerebrospinal fluid reveals potential specific patterns in multiple sclerosis patients 174
An acutely confused young woman 173
Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct Core 172
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 172
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 172
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 170
Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases 170
Sex differences in outcome after thrombectomy for acute ischemic stroke. A propensity score-matched study 169
CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke 169
The role of HLA-Class Ib molecules in immune-related diseases, tumors, and infections 169
Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: The BIO-AX-TBI study protocol 169
Translational stroke research review: Using the mouse to model human futile recanalization and reperfusion injury in ischemic brain tissue 169
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 168
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis 166
Pivotal role of multiphase computed tomography angiography for collateral assessment in patients with acute ischemic stroke 165
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 165
Sexual dimorphism in the cerebrospinal fluid total protein content 165
Early surgical treatment in unilateral coronoid hyperplasia and facial asymmetry 164
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 162
IV thrombolysis plus thrombectomy versus IV thrombolysis alone for minor stroke with anterior circulation large vessel occlusion from the IRETAS and Italian SITS-ISTR cohorts 161
Matrix metalloproteinases (MMP): Determination of different forms by different techniques may require different preanalytical strategies [2] 161
Time-dependent computed tomographic perfusion thresholds for patients with acute ischemic stroke 161
Mechanical thrombectomy in patients with heart failure: the Italian registry of Endovascular Treatment in Acute Stroke 160
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 160
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 159
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 158
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management 156
Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage 156
Epilepsy in primary cerebral tumors: The characteristics of epilepsy at the onset (results from the PERNO study-Project of Emilia Romagna Region on Neuro-Oncology) 156
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 155
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 154
Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA 153
Non-contrast CT markers of intracerebral hemorrhage expansion: the influence of onset-to-CT time. 153
A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma 153
Totale 20.542
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.540 59 93 159 71 48 97 59 172 90 78 160 454
2022/20232.861 327 770 102 109 104 508 431 103 239 29 71 68
2023/20241.676 28 215 262 68 117 138 75 356 60 144 111 102
2024/202510.159 429 1.234 805 1.589 2.601 1.237 183 408 526 300 379 468
2025/202616.403 1.236 2.115 1.675 2.401 1.469 479 1.379 853 950 1.035 759 2.052
2026/2027612 612 0 0 0 0 0 0 0 0 0 0 0
Totale 42.470